Legacy Financial Advisors, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Legacy Financial Advisors, Inc.

$527 Million
Q2 2025

A detailed history of Legacy Financial Advisors, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Legacy Financial Advisors, Inc. holds 999 shares of REGN stock, worth $584,724. This represents 0.1% of its overall portfolio holdings.

Number of Shares

999

Previous 992 0.71%

Holding current value

$584,724

Previous $629,000 16.69%

% of portfolio

0.1%

Previous 0.13%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	BUY	$483.07 - $625.6 $3,381 - $4,379	7 Added 0.71%	999 $524,000
Q1 2025 May 14, 2025	BUY	$634.14 - $744.83 $167,412 - $196,635	264 Added 36.26%	992 $629,000
Q4 2024 Feb 13, 2025	SELL	$701.85 - $1046.91 $116,507 - $173,787	-166 Reduced 18.57%	728 $518,000
Q3 2024 Nov 13, 2024	BUY	$1024.09 - $1201.76 $16,385 - $19,228	16 Added 1.82%	894 $939,000
Q2 2024 Aug 13, 2024	BUY	$883.2 - $1071.19 $60,940 - $73,912	69 Added 8.53%	878 $922,000
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $54,161 - $59,601	60 Added 8.01%	809 $778,000
Q4 2023 Feb 06, 2024	BUY	$775.18 - $881.7 $62,789 - $71,417	81 Added 12.13%	749 $657,000
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $115,639 - $141,009	167 Added 33.33%	668 $549,000
Q2 2023 Aug 08, 2023	BUY	$700.03 - $830.35 $32,201 - $38,196	46 Added 10.11%	501 $359,000
Q1 2023 May 03, 2023	BUY	$680.49 - $826.97 $28,580 - $34,732	42 Added 10.17%	455 $373,000
Q4 2022 Feb 06, 2023	BUY	$705.89 - $766.39 $5,647 - $6,131	8 Added 1.98%	413 $297,000
Q3 2022 Nov 09, 2022	SELL	$573.97 - $724.32 $6,313 - $7,967	-11 Reduced 2.64%	405 $279,000
Q2 2022 Aug 08, 2022	BUY	$548.35 - $738.84 $1,096 - $1,477	2 Added 0.48%	416 $246,000
Q1 2022 May 04, 2022	BUY	$595.12 - $698.43 $44,038 - $51,683	74 Added 21.76%	414 $289,000
Q4 2021 Feb 04, 2022	BUY	$543.48 - $670.97 $184,783 - $228,129	340 New	340 $215,000
Q2 2019 Aug 07, 2019	SELL	$299.6 - $414.82 $4,494 - $6,222	-15 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$372.08 - $439.57 $3,720 - $4,395	10 Added 200.0%	15 $6,000
Q4 2018 Jan 16, 2019	SELL	$335.82 - $403.04 $3,022 - $3,627	-9 Reduced 64.29%	5 $2,000
Q2 2018 Jul 17, 2018	BUY	$284.6 - $344.99 $2,276 - $2,759	8 Added 133.33%	14 $5,000
Q4 2017 Feb 09, 2018	BUY	$358.63 - $469.95 $2,151 - $2,819	6	6 $2,000

Others Institutions Holding REGN

# of Institutions

1,431

Shares Held

88.9M

Call Options Held

1.98M

Put Options Held

1.75M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $62.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Legacy Financial Advisors, Inc. with notifications on news.

Account

Legacy Financial Advisors, Inc. Regeneron Pharmaceuticals, Inc. Transaction History